0000819050-23-000008.txt : 20230126
0000819050-23-000008.hdr.sgml : 20230126
20230126184942
ACCESSION NUMBER: 0000819050-23-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230124
FILED AS OF DATE: 20230126
DATE AS OF CHANGE: 20230126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McAvoy David R.
CENTRAL INDEX KEY: 0001758842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 23559059
MAIL ADDRESS:
STREET 1: C/O ENDOCYTE, INC., 3000 KENT AVENUE
STREET 2: SUITE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Brickell Biotech, Inc.
DATE OF NAME CHANGE: 20190830
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
4
1
wf-form4_167477696231987.xml
FORM 4
X0306
4
2023-01-24
0
0000819050
Fresh Tracks Therapeutics, Inc.
FRTX
0001758842
McAvoy David R.
C/O FRESH TRACKS THERAPEUTICS, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER
CO
80301
0
1
0
0
Gen Counsel, CCO, & Secretary
Restricted Stock Units
2023-01-24
4
A
0
20000
0
A
Common Stock
20000.0
20000
D
Each restricted stock unit represents a contingent right to receive one share of issuer common stock upon settlement.
The restricted stock units vest in full on the first anniversary of the grant date.
/s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed)
2023-01-26